References
- ChenHBiWCaoBA novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200Eur J Pharmacol2010627697419879873
- MiettinenaSGrenmandSYlikomiaTInhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposureAnticancer Drugs2009206776
- AlexiouCSchmidRJJurgonsRTargeting cancer cells: magnetic nanoparticles as drug carriersEur Biophys J20063544645016447039
- NobsLBucheggerFCurnyRCurrent methods for attaching targeting ligands to liposomes and nanoparticlesJ Pharm Sci2004931980199215236448
- AllenTMLigand-targeted therapeutics in anticancer therapyNat Rev Cancer2002275076312360278
- DiasAMHussainAMarcosASA biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharidesBiotechnol Adv2011914215520959138
- ChengJWuWWChenBAEffect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cellsInt J Nanomedicine2009420921619918367
- ChenBAChengJShenMFMagnetic nanoparticles of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsInt J Nanomedicine20094657119421371
- WangJChenBAChengJSynthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles in vitroInt J Nanomedicine2010620321121445276
- KohoriFSakaiKAoyagiTControl of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly (N- sopropylacrylamide-co-N, N- imethylacrylamide)-bpoly(D L-lactide)Colloids Surf B Biointerfaces199916195205
- JainTKRicheyJStrandMMagnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imagingBiomaterials2008294012402118649936
- RossDDNovel mechanisms of drug resistance in leukemiaLeukemia2000346747310720143
- GarcíaMGAlanizLLopesECInhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell linesLeuk Res2005291425143415982733
- ThomasHColeyHMOvercoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoproteinCancer Control20031015916512712010
- GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer20022485811902585
- JinJWangFPWeiHReversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrineJ Lipid Res200647515816215259
- WangJQChenBAChengJComparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent resistance to adriamycin in human leukemia cell line K562/A02Ai Zheng20082749149518479598
- TsuruoTNaitoMTomidaAMolecular targeting therapy of cancer: drug resistance, apoptosis and survival signalCancer Sci200394152112708468
- JohnstoneRWRuefliAALoweSWApoptosis: a link between cancer genetics and chemotherapyCell200210815316411832206
- YangEKorsmeyerSJMolecular thanatopsis: a discourse on the BCL2 family and cell deathBlood1996883864018695785
- Rodriguez-NietoSZhivotovskyBRole of alterations in the apoptotic machinery in sensitivity of cancer cells to treatmentCurr Pharm Des2006124411442517168751
- CondorelliGMoriscoCStassiGIncreased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the ratCirculation1999993071307810368127
- KoCHShenSCHsuCSMitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascadeBiochem Pharmacol20056991392715748703
- SuzukiaAItoTKawanoHSurvivin initiates ptrocaspase 3/p21complex formation as result of interaction with Cdk4 to resist Fas-mediated cell deathOncogene2000191346135310713676